Anatomical and Dose Changes of Gross Tumour Volume and Parotid Glands for Head and Neck Cancer Patients during Intensity-modulated Radiotherapy: Effect on the Probability of Xerostomia Incidence

S. Marzi, P. Pinnarò, D. D'Alessio, L. Strigari, V. Bruzzaniti, C. Giordano, G. Giovinazzo, L. Marucci

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: To quantify the changes in dose as well as in the prediction of parotid gland toxicity due to anatomical changes during therapy of head and neck cancer patients. Materials and methods: Fifteen patients with advanced locoregional head and neck cancer, with no evidence of distant metastasis, were enrolled in a prospective study. All patients were treated with intensity-modulated radiotherapy. Multiple computed tomography scans were repeated at the end of each treatment week. The original treatment plans were copied to the per-treatment scans to create hybrid plans. The normal tissue complication probability (NTCP) was calculated assuming the end point to be grade ≥3 xerostomia according to the Radiation Therapy Oncology Group late toxicity scale. Results: The gross tumour volume dose coverage was slightly affected by the anatomical changes, whereas the mean dose (D mean) to the parotids changed from 26.1 ± 6.0 to 27.4 ± 7.4 Gy, with a mean increase of 0.22 Gy/treatment week. Consequently, the mean NTCP increased from 0.15 ± 0.06 to 0.18 ± 0.10, primarily due to a few patients exhibiting a marked increase. The absolute gross tumour volume shrinkage and the percentage parotids shrinkage were the best independent predictors for the NTCP variations. Conclusions: On average, the increase in the parotids D mean as well as in NTCP during treatment is limited, and the observed variations were strongly patient-dependent.

Original languageEnglish
JournalClinical Oncology
Volume24
Issue number3
DOIs
Publication statusPublished - Apr 2012

Keywords

  • Head and neck cancer
  • Intensity-modulated radiotherapy
  • Normal tissue complication probability
  • Parotid glands

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Anatomical and Dose Changes of Gross Tumour Volume and Parotid Glands for Head and Neck Cancer Patients during Intensity-modulated Radiotherapy: Effect on the Probability of Xerostomia Incidence'. Together they form a unique fingerprint.

Cite this